Z-0622-2019 Class II Terminated

Recalled by Clark Laboratories, Inc. (dba,Trinity Biotech USA) — Jamestown, NY

FDA device recall Z-0622-2019 was initiated by Clark Laboratories, Inc. (dba,Trinity Biotech USA) on November 1, 2018 and is designated Class II. Reason for recall: lack of 510K The recall status is terminated (terminated June 21, 2022). Affected quantity: 252 units.

Recall Details

Product Type
Devices
Report Date
December 26, 2018
Initiation Date
November 1, 2018
Termination Date
June 21, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
252 units

Product Description

Genesys 1 Reagent, REF 01-03-0020 intended to be used with automated high performance liquid chromatography (HPLC) systems employing ion exchange chromatography. For in vitro diagnostic use only.

Reason for Recall

lack of 510K

Distribution Pattern

IL, WV, NJ, AZ, MD, UT

Code Information

all serial numbers